Evidence map›Paper›PMID 39448204›Full record

ArticleRMD open2024

The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases.

Yvonne M van der Kraan, Lianne Gensler, Davy Paap, Ellen Thovmasyan, Noa Ausma, Helene Kokol, Marlies Carbo, Stan C Kieskamp, Karina de Leeuw, Kornelis S M van der Geest and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yvonne M van der KraanRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-6809-6799
Lianne GenslerMedicine/Rheumatology, University of California San Francisco, San Francisco, California, USA.
Davy PaapRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Ellen ThovmasyanMedicine/Rheumatology, University of California San Francisco, San Francisco, California, USA.
Noa AusmaRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Helene KokolRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Marlies CarboRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-9234-0608
Stan C KieskampRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-5511-3761
Karina de LeeuwRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0003-0218-9364
Kornelis S M van der GeestRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0003-2798-6765
Hendrika BootsmaRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Anneke SpoorenbergRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Suzanne ArendsRheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands s.arends@umcg.nl.ORCID 0000-0002-4422-7640

Funding

Skeletal Biology and Biomechanics (SBB) CoreP30AR075055 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wenhan Chang · 2019 to 2026
$7.1M
NIAMS NIH HHS P30 AR075055
6 · The paper itself

Abstract

backgroundThe modified Short QUestionnaire to ASsess Health-enhancing physical activity (mSQUASH) was originally developed and validated in Dutch patients with axial spondyloarthritis (axSpA). To support world-wide distribution, applicability and comparability of measuring physical activity, our aim was to perform translation and cross-cultural adaptation of the mSQUASH into English, field testing in other rheumatic diseases and clinical validation in patients with axSpA.

methodsThe Dutch mSQUASH was translated into English according to forward-backward Beaton protocol. Semistructured interviews were conducted in representative samples of patients with axSpA (n=13), Sjögren's disease (n=10), systemic lupus erythematosus (n=10) and giant cell arteritis/polymyalgia rheumatica (n=10) to verify relevance, comprehensiveness and comprehensibility. For construct validity (n=95), Spearman correlations were used with clinical outcome assessments. For test-retest reliability (n=82), intraclass correlation coefficients (ICC) were calculated. For responsiveness (n=80), standardised response means (SRM) were calculated stratified by Anchor method.

resultsTranslation and cross-cultural adaptation of the mSQUASH into English were successfully carried out, which can serve as basis for other translations. Only minor adaptations and clarifications were implemented. Fair correlations were found between mSQUASH and Axial Spondyloarthritis Disease Activity Score (ρ=-0.31), Bath Ankylosing Spondylitis Functional Index (ρ=-0.37) and Assessment of SpondyloArthritis International Society-Health Index (ρ=-0.30). Test-retest reliability was very good (ICC: 0.87). Responsiveness corresponded to the direction of self-reported changes in physical activity (SRM: 0.72 for improved, 0.06 for stable and -0.74 for worsened).

conclusionThe mSQUASH showed good linguistic and face validity according to field testing in different rheumatic diseases. Clinical validation confirmed good construct validity, test-retest reliability and responsiveness in patients with axSpA, which supports the use of the mSQUASH in clinical practice and research.

Indexed as

ExerciseRheumatic DiseasesAdultAgedAxial SpondyloarthritisFemaleHumansMaleMiddle AgedNetherlandsReproducibility of ResultsSurveys and Questionnairesaxial spondyloarthritisepidemiologypatient reported outcome measures

Identifiers

PMID39448204
PMCPMC11499806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.